scholarly journals Pacing and Body Weight Changes During a Mountain Ultramarathon: Sex Differences and Performance

2021 ◽  
Vol 80 (1) ◽  
pp. 71-82
Author(s):  
Ignacio Martínez-Navarro ◽  
Antonio Montoya-Vieco ◽  
Eladio Collado ◽  
Barbara Hernando ◽  
Carlos Hernando
Keyword(s):  
Body Weight ◽  
Sex Differences ◽  
Sedentary Time ◽  
Body Weight Loss ◽  
Cardiopulmonary Exercise Test ◽  
Relative Speed ◽  
Weight Changes ◽  
Body Weight Changes ◽  
And Performance ◽  
Speed Fluctuations

Abstract The study was aimed at comparing pacing adopted by males and females in a 107-km mountain ultramarathon and assessing whether pacing-related variables were associated with intracompetition body weight changes and performance. Forty-seven athletes (29 males; 18 females) were submitted to a cardiopulmonary exercise test before the race. Athletes were also weighted before the start of the race, at three midpoints (33 km, 66 km and 84 km) and after the race. Pacing was analyzed using absolute and relative speeds and accelerometry-derived sedentary time spent during the race. Results showed that females spent less sedentary time (4.72 ± 2.91 vs. 2.62 ± 2.14%; p = 0.035; d = 0.83) and displayed a smaller body weight loss (3.01 ± 1.96 vs. 4.37 ± 1.77%; p = 0.048; d = 0.77) than males. No significant sex differences were revealed for speed variability, absolute and relative speed. In addition, finishing time was correlated with: speed variability (r = 0.45; p = 0.010), index of pacing (r = -0.63; p < 0.001) and sedentary time (r = 0.64; p < 0.001). Meanwhile, intracompetition body weight changes were related with both the absolute and relative speed in the first and the last race section. These results suggest that females, as compared with males, take advantage of shorter time breaks at aid stations. Moreover, performing a more even pacing pattern may be positively associated with performance in mountain ultramarathons. Finally, intracompetition body weight changes in those races should be considered in conjunction with running speed fluctuations.

Sex Differences in Severity of Inflammation-Induced Anorexia and Weight Loss

2004 ◽  
Vol 5 (4) ◽  
pp. 255-264 ◽  
Author(s):  
Terry A. Lennie
Keyword(s):  
Weight Loss ◽  
Body Weight ◽  
Sex Differences ◽  
Food Intake ◽  
Acute Inflammation ◽  
Sesame Oil ◽  
Female Rats ◽  
Male Rats ◽  
Weight Changes ◽  
Body Weight Changes

Food intake and body weight changes in response to induction of acute inflammation were examined in intact cycling females, ovariectomized females, and sham-operated male rats. In intact females, body weight and feeding responses were compared between rats in which inflammation was induced on day of estrus with rats in which inflammation was induced on day of diestrus. Anorexia and weight loss were more severe in the female rats with inflammation induced on estrus day, which coincides with peak serum estrogen levels. In ovariectomized females, inflammation was induced the day after rats received injections of estrogen, progesterone, or sesame oil (vehicle). Males received vehicle injections. Among female rats, the group that received estradiol injections the previous day displayed the most severe anorexia. The least severe anorexia was observed in female rats that received progesterone the previous day. Food intake of female rats that received vehicle injections prior to induction of inflammation was greater than the rats receiving estrogen but less than the rats receiving progesterone. Male rats displayed the most severe anorexia and greatest weight loss. These data suggest that, although females exposed to estradiol prior to induction of acute inflammation display more severe anorexia than those exposed to progesterone, it may be that progesterone attenuates severity of anorexia rather than estrogen solely potentiating severity. Male rats, however, appear to experience the most severe anorexia in response to this form of inflammation.

scholarly journals Two-year follow-up cohort study focused on gender-specific associations between socioeconomic status and body weight changes in overweight and obese middle-aged and older adults

BMJ Open ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. e050127
Author(s):  
Malgorzata Biskup ◽  
Pawel Macek ◽  
Stanislaw Gozdz ◽  
Malgorzata Terek-Derszniak ◽  
Halina Krol ◽  
...  
Keyword(s):  
Socioeconomic Status ◽  
Weight Loss ◽  
Body Weight ◽  
Low Income ◽  
Body Weight Loss ◽  
Occupational Activity ◽  
Weight Changes ◽  
Body Weight Changes ◽  
Gender Specific

ObjectiveAs overall spread of obesity in populations is generally acknowledged to result from unhealthy lifestyles rather than individual genetic makeup, this study aimed to gain specific insights into its determinants through assessing the prevalent associations between individual socioeconomic status (SES) and weight loss in overweight and obese men and women.MethodsA prospective, 2-year follow-up study covered 3362 (38.0% men) respondents, aged 43–64 years, body mass index ≥25 kg/m2. Changes in body weight were estimated as a percentage of initial weight. Three categories of changes were defined: gained ≥3%, stable (gained <3% or lost <3%), lost ≥3%. Body weight loss was determined against three categories: lost ≥3 to <5%, lost ≥5 to <10%, lost ≥10%. Select SES variables (ie, gender, age, education, marital status, occupational activity and income) were determined in line with the Health Status Questionnaire. The associations between SES and body weight changes were analysed with the aid of logistic regression models. The results were presented as ORs with 95% CIs.ResultsOnly 18% of the respondents had complied with the medical recommendations on weight loss. Significant differences were encountered between the gender, age and occupational activity variables and the weight loss one. Multifactorial models were used to determine the following gender-specific associations between SES and weight loss. Men with moderate income had significantly higher odds for weight loss (≈75%), as compared with the higher earners, whereas women with low income, occupationally inactive, had significantly higher odds (≈30% and ≈50%, respectively), as compared with the high earners and occupationally active ones.ConclusionsLower education, male gender, lower income per household, older age and unemployment status were the established factors predisposing to obesity. While aiming to ensure effectiveness of the measures specifically aimed at preventing obesity, population groups deemed most at risk of potential weight gain must prior be identified.

scholarly journals Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs

2009 ◽  
Vol 296 (6) ◽  
pp. E1311-E1318 ◽  
Author(s):  
Joyce M. Richey ◽  
Orison O. Woolcott ◽  
Darko Stefanovski ◽  
L. Nicole Harrison ◽  
Dan Zheng ◽  
...  
Keyword(s):  
Body Weight ◽  
Adipose Tissue ◽  
Food Intake ◽  
Metabolic Rate ◽  
Resting Metabolic Rate ◽  
Subcutaneous Fat ◽  
Body Weight Loss ◽  
Weight Changes ◽  
High Fat ◽  
Body Weight Changes

We investigated whether rimonabant, a type 1 cannabinoid receptor antagonist, reduces visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) in dogs maintained on a hypercaloric high-fat diet (HHFD). To determine whether energy expenditure contributed to body weight changes, we also calculated resting metabolic rate. Twenty male dogs received either rimonabant (1.25 mg·kg−1·day−1, orally; n = 11) or placebo ( n = 9) for 16 wk, concomitant with a HHFD. VAT, SAT, and nonfat tissue were measured by magnetic resonance imaging. Resting metabolic rate was assessed by indirect calorimetry. By week 16 of treatment, rimonabant dogs lost 2.5% of their body weight ( P = 0.029), whereas in placebo dogs body weight increased by 6.2% ( P < 0.001). Rimonabant reduced food intake ( P = 0.027), concomitant with a reduction of SAT by 19.5% ( P < 0.001). In contrast with the VAT increase with placebo ( P < 0.01), VAT did not change with rimonabant. Nonfat tissue remained unchanged in both groups. Body weight loss was not associated with either resting metabolic rate ( r2 = 0.24; P = 0.154) or food intake ( r2 = 0.24; P = 0.166). In conclusion, rimonabant reduced body weight together with a reduction in abdominal fat, mainly because of SAT loss. Body weight changes were not associated with either resting metabolic rate or food intake. The findings provide evidence of a peripheral effect of rimonabant to reduce adiposity and body weight, possibly through a direct effect on adipose tissue.

scholarly journals Isoquinoline Alkaloids in Sows’ Diet Reduces Body Weight Loss during Lactation and Increases IgG in Colostrum

Animals ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 2195
Author(s):  
Ester Arévalo Sureda ◽  
Xuemei Zhao ◽  
Valeria Artuso-Ponte ◽  
Sophie-Charlotte Wall ◽  
Bing Li ◽  
...  
Keyword(s):  
Gene Expression ◽  
Weight Loss ◽  
Body Weight ◽  
Body Weight Loss ◽  
Muscle Thickness ◽  
Passive Immunity ◽  
Isoquinoline Alkaloids ◽  
Back Muscle ◽  
Fat Thickness ◽  
And Performance

Isoquinoline alkaloids (IQ) exert beneficial antimicrobial and anti-inflammatory effects in livestock. Therefore, we hypothesized that supplementing sows’ diets with IQ during gestation would decrease farrowing stress, affecting the piglets’ development and performance. Sows were divided into: IQ1, supplemented with IQ from gestation day 80 (G80) to weaning; IQ2, supplemented from gestation day 110 (G110) to weaning, and a non-supplemented (NC) group. Sow body weight (BW), feed intake, back-fat thickness and back-muscle thickness were monitored. Cortisol, glucose and insulin were measured in sows’ blood collected 5 d before, during, and after 7 d farrowing. Protein, fat, IgA and IgG were analyzed in the colostrum and milk. Piglets were monitored for weight and diarrhea score, and for ileum histology and gene expression 5 d post-weaning. IQ-supplemented sows lost less BW during lactation. Glucose and insulin levels were lower in the IQ groups compared to NC-sows 5 d before farrowing and had higher levels of protein and IgG in their colostrum. No other differences were observed in sows, nor in the measured parameters in piglets. In conclusion, IQ supplementation affected sows’ metabolism, reducing body weight loss during lactation. Providing IQ to sows from their entrance into the maternity barn might be sufficient to induce these effects. IQ improved colostrum quality, increasing the protein and IgG content, improving passive immunity for piglets.

Pre-lambing supplementation of gadic ewes in western Afghanistan

1980 ◽  
Vol 95 (1) ◽  
pp. 39-45
Author(s):  
I. D. McArthur
Keyword(s):  
Body Weight ◽  
Economic Benefits ◽  
Basic Information ◽  
Selective Feeding ◽  
Weight Changes ◽  
Body Weight Changes ◽  
Weight Losses ◽  
Sheep Production

SummaryA survey of sheep production was undertaken in rangeland areas of western Afghanistan to provide basic information of ewe body-weight changes throughout the year and on production variables, including mortality and lambing performance. Ewes lost up to 31% of body weight between December and March and mortality over the same period was 7%. On the basis of the results of this survey, an experiment was made to test the effect on lambing performance of pre-lambing supplementation of range-based ewes.Supplementation reduced weight losses in ewes, but the feeding treatments did not produce significant results in terms of lamb birth weights or survival to 10 days. However, there were indications that selective feeding of weak ewes can produce economic benefits, given that the costs of supervising such animals are minimal and the price of grain supplements is low relative to the price of meat.

Anti-COVID-19 measures threaten our healthy body weight: Changes in sleep and external synchronizers of circadian clocks during confinement

2021 ◽  
Author(s):  
Luis Baquerizo-Sedano ◽  
J.A. Chaquila ◽  
Luis Aguilar ◽  
J.M. Ordovás ◽  
Pedro González-Muniesa ◽  
...  
Keyword(s):  
Body Weight ◽  
Circadian Clocks ◽  
Weight Changes ◽  
Body Weight Changes ◽  
Healthy Body Weight ◽  
Healthy Body

scholarly journals Secretogranin II binds to secretogranin III and forms secretory granules with orexin, neuropeptide Y, and POMC

2009 ◽  
Vol 202 (1) ◽  
pp. 111-121 ◽  
Author(s):  
Kikuko Hotta ◽  
Masahiro Hosaka ◽  
Atsushi Tanabe ◽  
Toshiyuki Takeuchi
Keyword(s):  
Body Weight ◽  
Neuropeptide Y ◽  
Secretory Granules ◽  
Immunohistochemical Analysis ◽  
Mrna Levels ◽  
Weight Changes ◽  
Body Weight Changes ◽  
Hypothalamic Area ◽  
Double Labeling ◽  
Secretogranin Ii

Functional variations in the secretogranin III (SCG3) gene are associated with susceptibility to obesity. SCG3 forms secretory granules with orexin, melanin-concentrating hormone (MCH), neuropeptide Y (NPY), and POMC in the hypothalamus. In this study, we screened proteins for SCG3-binding activity and identified secretogranin II (SCG2) using a yeast two-hybrid system. Immunoprecipitation revealed that SCG2 interacts with SCG3. In situ hybridization and immunohistochemistry indicated that SCG2 was highly expressed in the lateral hypothalamic area, paraventricular nucleus, and arcuate nucleus of the hypothalamus. Double-labeling immunohistochemical analysis demonstrated that SCG2 was expressed in orexin-, MCH-, NPY-, and POMC-expressing neurons. SCG2 was also coexpressed with SCG3. Upon introduction into neuroblastoma cells, SCG2 was expressed in the cytosol and formed granule-like structures with SCG3, orexin, NPY, or POMC. SCG3 bound to POMC; however, it did not bind to orexin, MCH, or NPY. By contrast, SCG2 formed aggregates with orexin, MCH, NPY, and POMC. SCG2 may act as a hormone carrier for orexin, MCH, NPY, and POMC by binding with SCG3, which targets proteins to the secretory granules. SCG2 mRNA levels increased along with those of SCG3, orexin, MCH, and NPY after a 24-h fast, suggesting that the SCG2/SCG3 system may respond in an adaptive manner to acute body weight changes. However, this SCG2/SCG3 system appears to be unresponsive to chronic body weight changes, such as diet-induced obesity or obesity in ob/ob mice. We suggest that SCG2, as well as SCG3, may be a potential regulator of food intake based on its capacity to accumulate appetite-related hormones into secretory granules.

Sign in / Sign up

Export Citation Format

Share Document